Literature DB >> 32399450

Anxiety and Suicidality in a Hospitalized Patient with COVID-19 Infection.

Danny Epstein1, Wisam Andrawis1, Ari M Lipsky2, Hiba Abu Ziad3, Moshe Matan4.   

Abstract

We describe the case of a young man admitted due to mild COVID-19 infection. During his hospitalization in an isolation ward, he had no respiratory distress or fever but developed symptoms consistent with anxiety and insomnia. Despite the appropriate supportive intervention, on hospital day 7, he attempted suicide by jumping from the third-floor ward. The patient underwent urgent surgery and was transferred to a level I trauma center under strict isolation. Our findings emphasize the importance of the mental health aspects of patients treated during the COVID-19 pandemic. LEARNING POINTS: The COVID-19 pandemic requires social distancing, quarantine and isolation, which may precipitate new psychiatric symptoms in people without mental illness or aggravate existing conditions.Mental health service providers, including psychiatrists, clinical psychologists and social workers, should be available in every facility taking care of COVID-19 patients.Health workers treating patients during the COVID-19 pandemic should be aware of symptoms of depression, anxiety, insomnia and/or distress developing in their patients and colleagues. © EFIM 2020.

Entities:  

Keywords:  COVID-19; Suicidality; distress; isolation; quarantine

Year:  2020        PMID: 32399450      PMCID: PMC7213822          DOI: 10.12890/2020_001651

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


CASE DESCRIPTION

A 34-year-old man with a medical history of diabetes mellitus and smoking, presented to the emergency room with a 4-day history of weakness, fever and cough. On admission, his temperature was 37.5°C, pulse was 102 bpm, blood pressure was 133/85 mmHg, and oxygen saturation was 96% while breathing ambient air. Breath sounds were diminished with crackles over the left lower lung field. Chest radiographs showed interstitial opacities in the left lower lobe. Laboratory tests were unremarkable except for mild lymphopenia and thrombocytopenia. Nasopharyngeal and oropharyngeal swabs for COVID-19 were obtained due to a history of exposure to COVID-19 patients. After a positive result was reported, the patient was admitted to an isolation ward. Treatment with antibiotics and hydroxychloroquine was initiated. Direct contact between the staff and the patient was purposely minimal; interaction was primarily via an electronic audio-video link. Visitors were prohibited. During his hospitalization, the patient had no fever or respiratory distress. However, he developed symptoms consistent with anxiety and insomnia. A supportive intervention was initiated by a team of social workers and treatment with brotizolam was commenced. On hospital day 7, the patient attempted suicide by jumping from the third-floor ward. Droplet and contact precautions were initiated, and he was transferred to the trauma bay. All staff caring for the patient wore personal protective equipment. The patient was intubated and transferred under strict infection control measures for computed tomography which revealed subdural and subarachnoid haemorrhages, bladder laceration and pelvic fracture with active bleeding. Due to haemodynamic instability, the patient was urgently transferred to the operating room for pelvic stabilization. The procedure was performed in a distal operating room and all possible precautions were taken to prevent infection spread and protect the staff, including shutting down air-conditioning and postponing other surgeries in the compound. After pelvic fixation, the patient was transferred to a level 1 trauma centre for neurosurgical intervention. Full sanitization of the operating room, trauma bay and radiology unit was carried out.

DISCUSSION

More than 1 000 000 people worldwide have been infected with COVID-19. Most of these patients are either hospitalized in isolated and specially designed clinical wards or self-quarantined at home. Although most of the global attention has been focused on the treatment of the respiratory and cardiovascular complications of the disease, a large proportion of COVID-19 patients are experiencing psychological problems, including anxiety, depression and stress[. Patients infected with a novel, potentially fatal virus may experience fear of the disease itself and also loneliness and anger, and anxiety for the welfare of friends and family. All of these emotions may be aggravated by fever, dyspnoea and weakness, as well as the adverse effects of treatments such as chloroquine and corticosteroid administration. Studies performed after the 2003 severe acute respiratory syndrome (SARS) and 2014 Ebola outbreaks indicated very high rates of psychological distress among those who had been quarantined. Suicide attempts were documented among some hospitalized patients. Long-term behavioural changes were also reported [. Most of the healthcare workers treating COVID-19 patients, usually working in internal medicine wards and ICUs, have only basic training in providing mental health care. A large proportion of the workers themselves develop symptoms of depression, anxiety, insomnia and/or distress [. Mental health service providers, including psychiatrists, clinical psychologists and social workers, should be made available in every facility taking care of COVID-19 patients. These services should be readily available through safe communication channels. Regular screening for depression, anxiety and suicidality should be instituted for both patients and healthcare personnel. Special attention should be paid to those with pre-existing psychiatric disease. Early detection of stress reactions may enable simple, efficient intervention to prevent further morbidity and mortality, and lessen the burden on already overwhelmed healthcare systems [.

CONCLUSION

Based on our unfortunate experience, we encourage clinicians to pay special attention to the mental health aspects of the COVID-19 pandemic.
  5 in total

1.  Is There a Case for Quarantine? Perspectives from SARS to Ebola.

Authors:  Donna Barbisch; Kristi L Koenig; Fuh-Yuan Shih
Journal:  Disaster Med Public Health Prep       Date:  2015-03-23       Impact factor: 1.385

Review 2.  Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other.

Authors:  S Folkman; S Greer
Journal:  Psychooncology       Date:  2000 Jan-Feb       Impact factor: 3.894

3.  Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed.

Authors:  Yu-Tao Xiang; Yuan Yang; Wen Li; Ling Zhang; Qinge Zhang; Teris Cheung; Chee H Ng
Journal:  Lancet Psychiatry       Date:  2020-02-04       Impact factor: 27.083

4.  Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.

Authors:  Jianbo Lai; Simeng Ma; Ying Wang; Zhongxiang Cai; Jianbo Hu; Ning Wei; Jiang Wu; Hui Du; Tingting Chen; Ruiting Li; Huawei Tan; Lijun Kang; Lihua Yao; Manli Huang; Huafen Wang; Gaohua Wang; Zhongchun Liu; Shaohua Hu
Journal:  JAMA Netw Open       Date:  2020-03-02

Review 5.  The psychological impact of quarantine and how to reduce it: rapid review of the evidence.

Authors:  Samantha K Brooks; Rebecca K Webster; Louise E Smith; Lisa Woodland; Simon Wessely; Neil Greenberg; Gideon James Rubin
Journal:  Lancet       Date:  2020-02-26       Impact factor: 79.321

  5 in total
  15 in total

1.  Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort.

Authors:  Vito Fiore; Andrea De Vito; Chiara Fanelli; Nicholas Geremia; Elija Princic; Alessandra Nivoli; Ivana Maida; Liliana Lorettu; Giordano Madeddu; Sergio Babudieri
Journal:  Med Princ Pract       Date:  2021-09-28       Impact factor: 1.927

2.  Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.

Authors:  Paola Gualtieri; Carmela Falcone; Lorenzo Romano; Sebastiano Macheda; Pierpaolo Correale; Pietro Arciello; Nicola Polimeni; Antonino De Lorenzo
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

3.  Depressive, anxiety, and insomnia symptoms between population in quarantine and general population during the COVID-19 pandemic: a case-controlled study.

Authors:  Chengmin Wang; Weidong Song; Xiaohui Hu; Shaoguang Yan; Xing Zhang; Xunqiang Wang; Wenli Chen
Journal:  BMC Psychiatry       Date:  2021-02-16       Impact factor: 3.630

4.  Psychiatric Manifestations of COVID-19 and Their Social Significance.

Authors:  Radek Ptacek; Hana Ptackova; Anders Martin; George B Stefano
Journal:  Med Sci Monit       Date:  2020-12-16

Review 5.  Stroke Care during the COVID-19 Pandemic: International Expert Panel Review.

Authors:  Narayanaswamy Venketasubramanian; Craig Anderson; Hakan Ay; Selma Aybek; Waleed Brinjikji; Gabriel R de Freitas; Oscar H Del Brutto; Klaus Fassbender; Miki Fujimura; Larry B Goldstein; Roman L Haberl; Graeme J Hankey; Wolf-Dieter Heiss; Isabel Lestro Henriques; Carlos S Kase; Jong S Kim; Masatoshi Koga; Yoshihiro Kokubo; Satoshi Kuroda; Kiwon Lee; Tsong-Hai Lee; David S Liebeskind; Gregory Y H Lip; Stephen Meairs; Roman Medvedev; Man Mohan Mehndiratta; Jay P Mohr; Masao Nagayama; Leonardo Pantoni; Panagiotis Papanagiotou; Guillermo Parrilla; Daniele Pastori; Sarah T Pendlebury; Luther Creed Pettigrew; Pushpendra N Renjen; Tatjana Rundek; Ulf Schminke; Yukito Shinohara; Wai Kwong Tang; Kazunori Toyoda; Katja E Wartenberg; Mohammad Wasay; Michael G Hennerici
Journal:  Cerebrovasc Dis       Date:  2021-03-23       Impact factor: 2.762

6.  Negative Appraisals of the COVID-19 Social Impact Associated With the Improvement of Depression and Anxiety in Patients After COVID-19 Recovery.

Authors:  Wentao Chen; Yumeng Ju; Bangshan Liu; Mei Huang; Aiping Yang; Yun Zhou; Mi Wang; Mei Liao; Kongliang Shu; Jiyang Liu; Yan Zhang
Journal:  Front Psychiatry       Date:  2021-04-15       Impact factor: 4.157

7.  Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.

Authors:  Massimo Caracciolo; Pierpaolo Correale; Carmelo Mangano; Giuseppe Foti; Carmela Falcone; Sebastiano Macheda; Maria Cuzzola; Marco Conte; Antonella Consuelo Falzea; Eleonora Iuliano; Antonella Morabito; Michele Caraglia; Nicola Polimeni; Anna Ferrarelli; Demetrio Labate; Marco Tescione; Laura Di Renzo; Gaetano Chiricolo; Lorenzo Romano; Antonino De Lorenzo
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 8.  The SARS-CoV-2 and mental health: From biological mechanisms to social consequences.

Authors:  Dorota Szcześniak; Anna Gładka; Błażej Misiak; Agnieszka Cyran; Joanna Rymaszewska
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-28       Impact factor: 5.067

9.  Mental Well-Being (Depression, Loneliness, Insomnia, Daily Life Fatigue) during COVID-19 Related Home-Confinement-A Study from Poland.

Authors:  Adrian Bartoszek; Dariusz Walkowiak; Agnieszka Bartoszek; Grzegorz Kardas
Journal:  Int J Environ Res Public Health       Date:  2020-10-12       Impact factor: 3.390

Review 10.  Neuropsychiatric Complications of COVID-19.

Authors:  Zev M Nakamura; Rebekah P Nash; Sarah L Laughon; Donald L Rosenstein
Journal:  Curr Psychiatry Rep       Date:  2021-03-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.